Noxopharm marks FDA milestone

By Megan Brodie 2 years ago | In Companies
  • 2 years ago

23 March 2022 Sydney-based Noxopharm has secured Orphan Drug Designation (ODD) for its soft tissue…

This is subscriber-only content. Please login to continue reading.